Optimal treatment for chronic active Epstein-Barr virus disease.

@article{Cohen2009OptimalTF,
  title={Optimal treatment for chronic active Epstein-Barr virus disease.},
  author={Jeffrey I. Cohen},
  journal={Pediatric transplantation},
  year={2009},
  volume={13 4},
  pages={
          393-6
        }
}
Epstein-Barr virus (EBV) is a ubiquitous virus that infects at least 95% of the population. Most persons are infected during infancy and early childhood and are asymptomatic or have nonspecific symptoms (1). Infection of adolescents and young adults with EBV often results in infectious mononucleosis with fever, lymphadenopathy, sore throat, and splenomegaly. Additional signs and symptoms can include fatigue, headache, hepatomegaly, and rash. EBV is also associated with a number of malignancies… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

Recombinant Interferon Gamma in the Treatment of Chronic Epstein-Barr Virus Infection

Rakityanskaya Irina Anisimovna, TS Ryabova, UA Todzhibaev, AA Kalashnikova
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

Dual Infection with Hepatitis B and Epstein-Barr Virus Presenting with Severe Jaundice, Coagulopathy, and Hepatitis B Virus Chronicity Outcome

Sirish C. Rao, Imran Ashraf, +3 authors Veysel Tahan
  • The American journal of case reports
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND